首页> 外文期刊>BioMed research international >Development of a Broad-Range 23S rDNA Real-Time PCR Assay for the Detection and Quantification of Pathogenic Bacteria in Human Whole Blood and Plasma Specimens
【24h】

Development of a Broad-Range 23S rDNA Real-Time PCR Assay for the Detection and Quantification of Pathogenic Bacteria in Human Whole Blood and Plasma Specimens

机译:广泛的23S rDNA实时PCR检测试剂盒的开发,用于检测和定量人类全血和血浆标本中的病原细菌

获取原文
       

摘要

Molecular methods are important tools in the diagnosis of bloodstream bacterial infections, in particular in patients treated with antimicrobial therapy, due to their quick turn-around time. Here we describe a new broad-range real-time PCR targeting the 23S rDNA gene and capable to detect as low as 10 plasmid copies per reaction of targeted bacterial 23S rDNA gene. Two commercially available DNA extraction kits were evaluated to assess their efficiency for the extraction of plasma and whole blood samples spiked with different amount of eitherStaphylococcus aureusorEscherichia coli, in order to find the optimal extraction method to be used. Manual QIAmp extraction method with enzyme pre-treatment resulted the most sensitive for detection of bacterial load. Sensitivity of this novel assay ranged between 10 and 103 CFU per PCR reaction forE. coliandS. aureusin human whole blood samples depending on the extraction methods used. Analysis of plasma samples showed a 10- to 100-fold reduction of bacterial 23S rDNA in comparison to the corresponding whole blood specimens, thus indicating that whole blood is the preferential sample type to be used in this real-time PCR protocol. Our results thus show that the 23S rDNA gene represents an optimal target for bacteria quantification in human whole blood.
机译:分子方法是诊断血液细菌感染的重要工具,特别是在接受抗微生物治疗的患者中,由于其快速的治疗时间。在这里,我们描述了一种针对23S rDNA基因的新型宽范围实时PCR,每个靶细菌23S rDNA基因的反应每次检测低至10个质粒拷贝的能力。为了找到最佳的提取方法,对两种市售的DNA提取试剂盒进行了评估,以评估其对掺有不同量的金黄色葡萄球菌或大肠杆菌的加标血浆和全血样品的提取效率。手工QIAmp提取方法和酶预处理对检测细菌负荷最为敏感。每种PCR反应对E而言,这种新颖测定的灵敏度在10至103 CFU之间。大肠埃希氏菌。人全血样品中的金黄色葡萄球菌取决于所使用的提取方法。血浆样品的分析显示,与相应的全血样品相比,细菌23S rDNA减少了10到100倍,因此表明全血是此实时PCR方案中使用的优先样品类型。因此,我们的结果表明23S rDNA基因代表了人类全血中细菌定量的最佳靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号